MGP Ingredients (MGPI) Tops Q2 EPS by 24c, beats revenue, provides outlook

MGP Ingredients (NASDAQ: MGPI) reported Q2 EPS of $1.49, $0.24 better than the analyst estimate of $1.25. Revenue for the quarter came in at $209 million versus the consensus estimate of $205.15 million.
Outlook:

Sales are projected to be in the range of $815 million to $835 million vs. consensus of $830.75M.
Adjusted EBITDA is expected to be in the range of $187 million to $192 million.
Adjusted basic EPS is forecasted to be in the $5.35 to $5.50 range vs. consensus of $5.20, with basic weighted average shares outstanding expected to be approximately 22.1 million at year end.

For earnings history and earnings-related data on MGP Ingredients (MGPI) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance